Suara.com – Covid-19 Vaccine A new version designed to fight the South African coronavirus variant or Beta variant has been given to people in the UK for the first time.
As we know, the world is facing the attack of a number of variants of the corona virus which has increased the cases of infection. Therefore, the University of Oxford conducted a series of trials to create a new Covid-19 vaccine.
The academics who helped make AstraZeneca vaccine has also updated its Covid-19 vaccine, specifically to fight the Beta variant detected in South Africa.
Although these Beta variants are at low levels in the UK, a study shows that these Beta variants are 50 per cent more contagious than corona virus Covid-19 originally from China.
Also Read:
Head of IDI: Transmission of the Delta Variant Corona Virus is 10 Times Faster
Scientists also believe that this Beta variant is quite immune to the Covid-19 vaccine compared to other variants. As a result, the Beta variant became the prime candidate that prompted the AstraZeneca/Oxford team to test a new Covid-19 vaccine, called AZD2816 on 250 volunteers.
The volunteers came from the UK, Poland, Brazil and South Africa. Previously, doctors had tested the new Covid-19 vaccine made by the AstraZeneca team on mice in the laboratory.
Now, they are testing it on humans who have received two injections of the Covid-19 vaccine and it has been more than three months since the second injection. In addition, the volunteers are also eligible to participate.
“AZD2816 should help bolster an individual’s immune response to immune variants of the coronavirus,” Sir Mene Pangalos, Executive Vice President of R&D BioPharmaceuticals at AstraZeneca was quoted as saying. The Sun.
Professor Sir Andrew Pollard, chief investigator and director of the Oxford Vaccine Group at the University of Oxford, added that testing this new Covid-19 vaccine on a new variant of the coronavirus serves to ensure everyone is ready for the next pandemic or not.
Also Read:
New Findings, WHO Calls Lambda Variant Corona Virus Has Many Mutations
In addition, PHE is also increasing its control measures to reduce the number of Covid-9 cases due to new variants with improved contact tracing, rapid testing and isolation.
“PHE also continues to monitor changes or mutations of the Covid-19 coronavirus as it emerges, given the high overall number of coronavirus cases globally,” said Dr Andrew Lee, Director of Covid Incidents at Public Health England.
– .
